Olema Pharmaceuticals (OLMA) stock jumps 6% in a weak market — what to watch next

Olema Pharmaceuticals (OLMA) stock jumps 6% in a weak market — what to watch next

Olema Pharmaceuticals shares rose 5.8% to $25.99 Thursday afternoon, adding about $127 million in market value as broader indexes fell. Trading volume reached 926,000 shares. No new company news emerged, but traders are watching for Olema’s March update and progress on its late-stage palazestrant trial. The company reported over $500 million in cash and equivalents as of Dec. 31, 2025.
Intuit (INTU) stock drops about 8% as AI fears slam software — what traders watch next

Intuit (INTU) stock drops about 8% as AI fears slam software — what traders watch next

Intuit shares fell 7.5% to $498.09 in Thursday afternoon trading amid a sharp selloff in U.S. software stocks. The drop followed weak cloud forecasts from SAP and ServiceNow’s post-earnings slide, which pushed the S&P 500 Software and Services Index to a nine-month low. Investors are watching Intuit’s upcoming earnings for signs of tax-season demand.
Shopify stock price rises as SHOP bucks tech slump ahead of Feb. 11 earnings

Shopify stock price rises as SHOP bucks tech slump ahead of Feb. 11 earnings

Shopify shares rose 2.7% to $142.73 Thursday, outperforming a falling U.S. market ahead of its Feb. 11 earnings release. The stock swung between $137.47 and $144.00 during volatile trading. Major indexes and most e-commerce stocks declined, with the Nasdaq 100 ETF down 1.1%. Investors are watching Shopify’s gross merchandise volume and 2026 outlook amid sector-wide caution.
Lockheed Martin stock price jumps on Pentagon profit-share missile deal and upbeat 2026 outlook

Lockheed Martin stock price jumps on Pentagon profit-share missile deal and upbeat 2026 outlook

Lockheed Martin shares rose 4.7% to $625.61 after the Pentagon signed a profit-sharing deal to ramp up THAAD and Patriot interceptor production. The company’s 2026 revenue and profit forecast topped Wall Street estimates. Lockheed reported Q4 sales of $20.32 billion and net earnings of $1.3 billion. Investors are watching whether funding and factory capacity can meet higher output targets.
Arista stock dips as Big Tech AI-spend doubts hit Nasdaq; ANET earnings in focus

Arista stock dips as Big Tech AI-spend doubts hit Nasdaq; ANET earnings in focus

Arista Networks shares fell about 1% to $148.63 Thursday afternoon amid a broader tech sell-off following Microsoft’s earnings. Investors are focused on Arista’s Feb. 12 results and management’s outlook for cloud and AI demand. The stock had climbed 2.4% in the previous session. Wall Street indexes slipped as traders questioned whether AI spending will boost profits or lead to cuts.
Norwegian Cruise Line stock jumps nearly 10% as Royal Caribbean outlook lifts cruise shares

Norwegian Cruise Line stock jumps nearly 10% as Royal Caribbean outlook lifts cruise shares

Norwegian Cruise Line Holdings shares jumped nearly 10% to $22.86 Thursday as cruise stocks rallied after Royal Caribbean issued an upbeat 2026 profit forecast and strong “Wave” booking commentary. About 20 million Norwegian shares changed hands by early afternoon. Oil prices surged nearly 4% to a five-month high, raising cost concerns for cruise operators. Norwegian has not issued new financial updates this week.
Citigroup stock price today: Citi shares edge up as job cuts and arbitration fight hang over the tape

Citigroup stock price today: Citi shares edge up as job cuts and arbitration fight hang over the tape

Citigroup shares rose 0.3% to $114.53 Thursday afternoon, outperforming major indexes. Reuters reported the bank plans to cut about 1,000 jobs as part of a broader workforce reduction. Citi also asked a federal judge to move a former executive’s harassment lawsuit into arbitration. The bank filed new capital markets documents for structured notes tied to major stock indexes.
29 January 2026
Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher shares fell 2.6% to $592.08 after the company forecast 2026 adjusted profit below Wall Street estimates, citing continued weakness in U.S. academic and government funding. The firm projected 2026 adjusted EPS of $24.22–$24.80 and revenue of $46.3–$47.2 billion. Fourth-quarter revenue rose 7% to $12.21 billion. Investors are watching the timing of the Clario acquisition, expected to close by mid-2026.
Meta stock jumps nearly 10% after earnings, even with $135 billion AI spending plan

Meta stock jumps nearly 10% after earnings, even with $135 billion AI spending plan

Meta shares surged 10% to $735.36 Thursday after reporting a 24% jump in Q4 revenue to $59.89 billion, fueled by strong ad sales. The company forecast 2026 capital expenditures of $115–$135 billion, far above 2025 levels, to support AI expansion. Investors weighed the results against rising costs and legal risks. Meta also warned of regulatory challenges in its SEC filing.
Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health shares rose 1% to $345.44 Thursday, leading gains in managed-care stocks after policy and earnings volatility. The company forecast 2026 adjusted EPS of at least $25.50, below analyst expectations, and warned of revenue declines amid Medicaid and ACA headwinds. Medicare Advantage payments are set for a minimal 0.09% increase in 2027, rattling the sector. ACA enrollment for 2026 dropped to about 23 million as subsidies ended.
Brookdale Senior Living stock jumps on early 2025 results and fresh 2026 outlook ahead of Investor Day

Brookdale Senior Living stock jumps on early 2025 results and fresh 2026 outlook ahead of Investor Day

Brookdale Senior Living shares surged nearly 11% Thursday after releasing preliminary 2025 results and its first full-year 2026 forecast. The company projects 2026 adjusted EBITDA of $502 million to $516 million and expects RevPAR growth of 8% to 9%. Brookdale reported a 2025 net loss of about $263 million, including $71 million in non-cash impairment charges. Wall Street analysts raised price targets ahead of Investor Day.
Virtu Financial stock price jumps after blowout Q4; traders eye volatility next

Virtu Financial stock price jumps after blowout Q4; traders eye volatility next

Virtu Financial shares rose 5.9% to $39.72 after the company reported fourth-quarter net income of $280.6 million on $969.9 million in revenue. Trading income jumped 22.2% year-over-year to $664.9 million amid higher market volatility and volumes. The board declared a $0.24 per share dividend, payable March 16 to holders as of Feb. 27. Virtu ended 2025 with $1.13 billion in cash and $2.07 billion in long-term debt.
RTX stock price holds near $200 after Pratt exec flags easing engine squeeze

RTX stock price holds near $200 after Pratt exec flags easing engine squeeze

RTX shares rose 0.3% to $199.98 Thursday, bucking a broader market decline. A Pratt & Whitney executive said the jet-engine supply shortage should ease by decade’s end. RTX reported Q4 revenue of $24.24 billion, up 12%, and forecast 2026 adjusted sales at up to $93 billion. Investors weighed engine repair updates, tariffs, and pressure on defense contractor payouts.
Carnival (CCL) stock price jumps as Royal Caribbean’s upbeat outlook lifts cruise shares

Carnival (CCL) stock price jumps as Royal Caribbean’s upbeat outlook lifts cruise shares

Carnival shares jumped 8.6% to $31.19 Thursday after Royal Caribbean projected 2026 profits above expectations and reported strong bookings. Royal Caribbean soared 17.1%, Norwegian Cruise Line rose 10%, and Viking Holdings gained 5.2%. Carnival will pay a 15-cent dividend on Feb. 27 to holders as of Feb. 13. Investors await Carnival’s earnings update, expected around March 20, for details on bookings and costs.
Rocket Lab stock price falls as RKLB slips on Neutron schedule focus ahead of Feb. 26 results

Rocket Lab stock price falls as RKLB slips on Neutron schedule focus ahead of Feb. 26 results

Rocket Lab shares fell 3.1% to $85.84 as the Nasdaq dropped 1.4% Thursday afternoon. Investors tracked the arrival of Neutron’s “Hungry Hippo” hardware in Virginia and awaited a Feb. 26 earnings update for new launch timing. The company is reviewing a recent Stage 1 tank rupture that could affect Neutron’s schedule. Implied volatility on Rocket Lab options rose to 97.48, signaling expectations of sharp price swings.

Stock Market Today

Mitsubishi UFJ (MUFG) stock rises in Tokyo; election and BOJ rate signals set the next test

7 February 2026
Tokyo, Feb 8, 2026, 07:01 JST — Market closed. Mitsubishi UFJ Financial Group’s Tokyo-listed shares ended Friday up 2.5% at 2,951.5 yen, closing at the top of the day’s range after trading as low as 2,803 yen. (Investing.com) The move matters because MUFG is back where Japanese banks do their most sensitive risk-taking: the government bond market. Higher rates lift lending margins, but they also pressure bond portfolios. Those “unrealised losses” are paper losses on bonds the bank still holds, and they can swing quickly when yields move. That is not an academic point heading into the new week. Japan
Go toTop